The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 56,024 | 1,152,520 | SH | SOLE | 1,152,520 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 15 | 213 | SH | SOLE | 213 | 0 | 0 | ||
Acadia Healthcare Company, Inc. | Common | 00404A109 | 11,417 | 231,200 | SH | SOLE | 231,200 | 0 | 0 | ||
Accelerate Diagnostics, Inc. | Common | 00430H102 | 2,735 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Acceleron Pharma Inc. | Common | 00434H108 | 1,813 | 59,654 | SH | SOLE | 59,654 | 0 | 0 | ||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 6,584 | 1,466,368 | SH | SOLE | 1,466,368 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Note 2.00% 5/15/19 | 00767EAB8 | 10,546 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | ||
Affimed N.V. | Common | N01045108 | 2,881 | 1,405,324 | SH | SOLE | 1,405,324 | 0 | 0 | ||
Akorn, Inc. | Common | 009728106 | 10,992 | 327,735 | SH | SOLE | 327,735 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 91,363 | 750,905 | SH | SOLE | 750,905 | 0 | 0 | ||
Allergan plc | Shares | G0177J108 | 75,506 | 310,610 | SH | SOLE | 310,610 | 0 | 0 | ||
Allergan plc | Preferred Convertible Series A | G0177J116 | 4,340 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
Alliqua BioMedical, Inc. | Common | 019621200 | 611 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 604 | 47,300 | SH | SOLE | 47,300 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 9,170 | 114,966 | SH | SOLE | 114,966 | 0 | 0 | ||
AmerisourceBergen Corporation | Common | 03073E105 | 24,094 | 254,887 | SH | SOLE | 254,887 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 117,947 | 684,824 | SH | SOLE | 684,824 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 1,619 | 160,730 | SH | SOLE | 160,730 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y407 | 1,988 | 811,227 | SH | SOLE | 811,227 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 3,261 | 639,370 | SH | SOLE | 639,370 | 0 | 0 | ||
Argenx SE | Sponsored ADR | 04016X101 | 1,591 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 18,770 | 550,600 | SH | SOLE | 550,600 | 0 | 0 | ||
Auris Medical Holding AG | Common | H03579101 | 554 | 774,504 | SH | SOLE | 774,504 | 0 | 0 | ||
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 6,886 | 624,288 | SH | SOLE | 624,288 | 0 | 0 | ||
Avexis, Inc. | Common | 05366U100 | 822 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 701 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 143,759 | 529,774 | SH | SOLE | 529,774 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 45,568 | 501,745 | SH | SOLE | 501,745 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 1,394 | 13,273 | SH | SOLE | 13,273 | 0 | 0 | ||
Bristol-Myers Squibb Co. | Common | 110122108 | 10,392 | 186,500 | SH | SOLE | 186,500 | 0 | 0 | ||
Cardinal Health, Inc. | Common | 14149Y108 | 5,969 | 76,600 | SH | SOLE | 76,600 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 189,169 | 1,456,605 | SH | SOLE | 1,456,605 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B103 | 261 | 105,800 | SH | SOLE | 105,800 | 0 | 0 | ||
Cellectis S.A. | Sponsored ADR | 15117K103 | 8,011 | 310,250 | SH | SOLE | 310,250 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 15,385 | 192,600 | SH | SOLE | 192,600 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 12,856 | 127,100 | SH | SOLE | 127,100 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 2,149 | 286,472 | SH | SOLE | 286,472 | 0 | 0 | ||
Cigna Corporation | Common | 125509109 | 14,044 | 83,900 | SH | SOLE | 83,900 | 0 | 0 | ||
Clovis Oncology, Inc. | Common | 189464100 | 14,119 | 150,800 | SH | SOLE | 150,800 | 0 | 0 | ||
Coherus Biosciences, Inc. | Common | 19249H103 | 1,292 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 2,031 | 203,935 | SH | SOLE | 203,935 | 0 | 0 | ||
CVS Health Corporation | Common | 126650100 | 33,141 | 411,891 | SH | SOLE | 411,891 | 0 | 0 | ||
CytomX Therapeutics, Inc. | Common | 23284F105 | 8,216 | 530,092 | SH | SOLE | 530,092 | 0 | 0 | ||
DBV Technologies S.A. | Sponsored ADR | 23306J101 | 2,278 | 63,800 | SH | SOLE | 63,800 | 0 | 0 | ||
Dermira, Inc. | Common | 24983L104 | 11,274 | 386,900 | SH | SOLE | 386,900 | 0 | 0 | ||
DexCom, Inc. | Common | 252131107 | 6,181 | 84,500 | SH | SOLE | 84,500 | 0 | 0 | ||
Diplomat Pharmacy, Inc. | Common | 25456K101 | 6,833 | 461,712 | SH | SOLE | 461,712 | 0 | 0 | ||
Dynavax Technologies Corporation | Common | 268158201 | 3,330 | 345,050 | SH | SOLE | 345,050 | 0 | 0 | ||
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 4,454 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
Eli Lilly & Company | Common | 532457108 | 40,582 | 493,100 | SH | SOLE | 493,100 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 10,216 | 914,548 | SH | SOLE | 914,548 | 0 | 0 | ||
Entellus Medical, Inc. | Common | 29363K105 | 5,655 | 341,471 | SH | SOLE | 341,471 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 4,243 | 281,000 | SH | SOLE | 281,000 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 13,587 | 551,647 | SH | SOLE | 551,647 | 0 | 0 | ||
Express Scripts Holding Company | Common | 30219G108 | 5,394 | 84,500 | SH | SOLE | 84,500 | 0 | 0 | ||
Flex Pharma, Inc. | Common | 33938A105 | 614 | 159,549 | SH | SOLE | 159,549 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd | Shares | M46135105 | 4,317 | 930,398 | SH | SOLE | 930,398 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 1,454 | 19,000 | SH | SOLE | 19,000 | 0 | 0 | ||
GenMark Diagnostics, Inc. | Common | 372309104 | 1,104 | 93,349 | SH | SOLE | 93,349 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 179,083 | 2,530,131 | SH | SOLE | 2,530,131 | 0 | 0 | ||
GlaxoSmithKline plc | Shares | 37733W105 | 15,480 | 359,000 | SH | SOLE | 359,000 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | Common | 37890U108 | 3,419 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
Global Medical REIT Inc. | Common | 37954A204 | 656 | 73,400 | SH | SOLE | 73,400 | 0 | 0 | ||
HCA Healthcare, Inc. | Common | 40412C101 | 8,304 | 95,232 | SH | SOLE | 95,232 | 0 | 0 | ||
HCP, Inc. | Common | 40414L109 | 1,454 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
Healthcare Realty Trust Inc. | Common | 421946104 | 2,322 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Class A | 42225P501 | 1,431 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
Horizon Pharma plc | Shares | G4617B105 | 1,934 | 162,900 | SH | SOLE | 162,900 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 30,025 | 124,781 | SH | SOLE | 124,781 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 21,364 | 132,352 | SH | SOLE | 132,352 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 48,405 | 278,960 | SH | SOLE | 278,960 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 2,002 | 124,335 | SH | SOLE | 124,335 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 87,290 | 693,275 | SH | SOLE | 693,275 | 0 | 0 | ||
Innoviva, Inc. | Common | 45781M101 | 3,185 | 248,803 | SH | SOLE | 248,803 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 448 | 28,000 | SH | SOLE | 28,000 | 0 | 0 | ||
iShares Nasdaq Biotechnology ETF | Nasdaq Biotech ETF | 464287556 | 23,557 | 75,970 | SH | SOLE | 75,970 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 42,594 | 273,916 | SH | SOLE | 273,916 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 94,503 | 714,362 | SH | SOLE | 714,362 | 0 | 0 | ||
Juno Therapeutics, Inc. | Common | 48205A109 | 1,701 | 56,900 | SH | SOLE | 56,900 | 0 | 0 | ||
Karyopharm Therapeutics Inc. | Common | 48576U106 | 6,848 | 756,679 | SH | SOLE | 756,679 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 7,000 | 136,212 | SH | SOLE | 136,212 | 0 | 0 | ||
Mallinckrodt plc | Shares | G5785G107 | 2,774 | 61,900 | SH | SOLE | 61,900 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 23,496 | 142,800 | SH | SOLE | 142,800 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 12,969 | 1,007,717 | SH | SOLE | 1,007,717 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 51,504 | 580,326 | SH | SOLE | 580,326 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 94,423 | 1,473,295 | SH | SOLE | 1,473,295 | 0 | 0 | ||
Merus B.V. | Common | N5749R100 | 7,595 | 479,150 | SH | SOLE | 479,150 | 0 | 0 | ||
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 2,584 | 152,900 | SH | SOLE | 152,900 | 0 | 0 | ||
Mylan N.V. | Shares | N59465109 | 62,233 | 1,603,112 | SH | SOLE | 1,603,112 | 0 | 0 | ||
Myovant Sciences Ltd. | Common | G637AM102 | 4,680 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Nabriva Therapeutics plc | Shares | G63637105 | 1,677 | 149,334 | SH | SOLE | 149,334 | 0 | 0 | ||
NanoString Technologies, Inc. | Common | 63009R109 | 1,877 | 113,500 | SH | SOLE | 113,500 | 0 | 0 | ||
Natera, Inc. | Common | 632307104 | 5,275 | 485,758 | SH | SOLE | 485,758 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 25,873 | 562,467 | SH | SOLE | 562,467 | 0 | 0 | ||
Nevro Corp. | Common | 64157F103 | 14,486 | 194,621 | SH | SOLE | 194,621 | 0 | 0 | ||
New Senior Investment Group Inc. | Common | 648691103 | 5,708 | 567,997 | SH | SOLE | 567,997 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 33,276 | 398,662 | SH | SOLE | 398,662 | 0 | 0 | ||
Novavax, Inc. | Common | 670002104 | 657 | 571,000 | SH | SOLE | 571,000 | 0 | 0 | ||
Novo Nordisk A/S | Sponsored ADR | 670100205 | 9,320 | 217,300 | SH | SOLE | 217,300 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 15,144 | 458,616 | SH | SOLE | 458,616 | 0 | 0 | ||
Ovid Therapeutics Inc. | Common | 690469101 | 5,229 | 535,824 | SH | SOLE | 535,824 | 0 | 0 | ||
Paratek Pharmaceuticals, Inc. | Common | 699374302 | 12,845 | 533,000 | SH | SOLE | 533,000 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 2,817 | 37,300 | SH | SOLE | 37,300 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 27,211 | 810,087 | SH | SOLE | 810,087 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 10,688 | 530,672 | SH | SOLE | 530,672 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 14,358 | 2,837,573 | SH | SOLE | 2,837,573 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 7,651 | 102,000 | SH | SOLE | 102,000 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 17,702 | 202,537 | SH | SOLE | 202,537 | 0 | 0 | ||
Quorum Health Corporation | Common | 74909E106 | 98 | 23,725 | SH | SOLE | 23,725 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | Common | 74933V108 | 7,418 | 395,818 | SH | SOLE | 395,818 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 92,170 | 187,666 | SH | SOLE | 187,666 | 0 | 0 | ||
Retrophin, Inc. | Common | 761299106 | 3,257 | 167,949 | SH | SOLE | 167,949 | 0 | 0 | ||
The RMR Group Inc. | Class A | 74967R106 | 362 | 7,441 | SH | SOLE | 7,441 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 13,279 | 550,990 | SH | SOLE | 550,990 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 7,206 | 90,480 | SH | SOLE | 90,480 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 8,619 | 179,900 | SH | SOLE | 179,900 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 17,246 | 511,600 | SH | SOLE | 511,600 | 0 | 0 | ||
Seattle Genetics, Inc. | Common | 812578102 | 11,574 | 223,700 | SH | SOLE | 223,700 | 0 | 0 | ||
Senior Housing Properties Trust | Shares | 81721M109 | 13,216 | 646,554 | SH | SOLE | 646,554 | 0 | 0 | ||
Shire plc | Sponsored ADR | 82481R106 | 41,667 | 252,113 | SH | SOLE | 252,113 | 0 | 0 | ||
Spark Therapeutics, Inc. | Common | 84652J103 | 1,452 | 24,300 | SH | SOLE | 24,300 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 17,478 | 226,460 | SH | SOLE | 226,460 | 0 | 0 | ||
Syndax Pharmaceuticals, Inc. | Common | 87164F105 | 2,794 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 6,062 | 313,440 | SH | SOLE | 313,440 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 7,161 | 1,004,322 | SH | SOLE | 1,004,322 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 33,743 | 1,015,758 | SH | SOLE | 1,015,758 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 24,272 | 139,120 | SH | SOLE | 139,120 | 0 | 0 | ||
Trillium Therapeutics Inc. | Common | 89620X506 | 1,980 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 7,907 | 127,308 | SH | SOLE | 127,308 | 0 | 0 | ||
uniQure N.V. | Shares | N90064101 | 1,492 | 241,021 | SH | SOLE | 241,021 | 0 | 0 | ||
United Therapeutics Corporation | Common | 91307C102 | 5,703 | 43,961 | SH | SOLE | 43,961 | 0 | 0 | ||
Unitedhealth Group Inc. | Common | 91324P102 | 57,012 | 307,476 | SH | SOLE | 307,476 | 0 | 0 | ||
Universal Health Services, Inc. | Class B | 913903100 | 5,869 | 48,076 | SH | SOLE | 48,076 | 0 | 0 | ||
Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | 7,439 | 430,000 | SH | SOLE | 430,000 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 12,228 | 175,991 | SH | SOLE | 175,991 | 0 | 0 | ||
Verona Pharma plc | Sponsored ADR | 925050106 | 3,211 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 102,845 | 798,053 | SH | SOLE | 798,053 | 0 | 0 | ||
Welltower Inc. | 6.50% Preferred Perpetual | 95040Q203 | 13,252 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Welltower Inc. | Common | 95040Q104 | 1,602 | 21,400 | SH | SOLE | 21,400 | 0 | 0 | ||
Wright Medical Group N.V. | Ordinary Shares | N96617118 | 5,904 | 214,781 | SH | SOLE | 214,781 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 422 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 1,103 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
Zafgen, Inc. | Common | 98885E103 | 47 | 13,307 | SH | SOLE | 13,307 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 13,135 | 102,300 | SH | SOLE | 102,300 | 0 | 0 |